Clinical Trials Directory

Trials / Completed

CompletedNCT01569906

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Narrowband Ultraviolet B Phototherapy in Children With Moderate to Severe Atopic Eczema- an Observational Prospective Controlled Study

Status
Completed
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
Royal Victoria Infirmary · Academic / Other
Sex
All
Age
3 Years – 16 Years
Healthy volunteers
Not accepted

Summary

To assess prospectively, the response of moderate to severe atopic eczema to a standard course of narrowband ultraviolet B phototherapy by using validated objective and subjective scoring systems.

Detailed description

Children with moderate to severe atopic eczema prescribed a course of narrowband UVB phototherapy were scored (using validated scoring systems) objectively and subjectively before, during and after the course of treatment, as well as 3 and 6 months post treatment (to determine length of remission). Their scores were compared to a control group. The control group comprised children with moderate to severe atopic eczema who were offered UVB but were unable to undertake the treatment.

Conditions

Interventions

TypeNameDescription
RADIATIONNarrowband Ultraviolet B phototherapyTwice weekly exposures for a total of 24 exposures using a standard phototherapy protocol.

Timeline

Start date
2009-04-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2012-04-03
Last updated
2012-04-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01569906. Inclusion in this directory is not an endorsement.